Molecular Assemblies Closes $24M Series A

23 Apr, 2021

Molecular Assemblies Closes $24M Series A
Photo by STIL on Unsplash

– Molecular Assemblies is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products.
– The company announced that it has closed an oversubscribed $24m Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures.

Biotechnology Genetics Health Care North America
Crunchbase icon

Content report

The following text will be sent to our editors: